What Is a Left Bundle Branch Block? A Cardiologist’s Guide for Patients

If you’ve been told that your ECG shows a left bundle branch block, your first reaction was probably a mixture of confusion and concern. That’s a perfectly normal response. The name itself sounds alarming, and most patients have never heard the term before. In my cardiology practice in Encinitas, I explain left bundle branch block to patients regularly, and I’ve found that a clear understanding of what it means, what caused it, and what we should do about it goes a long way toward easing that initial worry.

Left bundle branch block, often abbreviated as LBBB, is an abnormality in the way electrical signals travel through your heart. It shows up as a specific pattern on an electrocardiogram (ECG or EKG). In some patients, LBBB is a benign finding that requires nothing more than monitoring. In others, it’s a red flag pointing to underlying heart disease that needs evaluation and treatment. The difference depends entirely on context, and that context is what I want to help you understand.

How Your Heart’s Electrical System Works

To make sense of LBBB, you first need a basic understanding of how your heart generates and conducts electrical impulses. Your heart is, at its core, an electrical organ. Every heartbeat begins with an electrical signal.

The signal starts at the sinoatrial (SA) node, a small cluster of specialized cells in the upper right chamber of your heart (the right atrium). The SA node is your heart’s natural pacemaker. It fires 60 to 100 times per minute at rest, generating the electrical impulse that triggers each heartbeat.

From the SA node, the electrical signal spreads through both atria (the upper chambers), causing them to contract and push blood into the ventricles (the lower chambers). The signal then reaches the atrioventricular (AV) node, a gateway between the atria and ventricles. The AV node briefly delays the signal, giving the ventricles time to fill with blood before they contract.

After passing through the AV node, the electrical impulse travels into the His bundle (pronounced “hiss”), a cord of specialized conducting fibers that penetrates through the tissue separating the atria from the ventricles. The His bundle then divides into two branches: the right bundle branch and the left bundle branch.

The right bundle branch is a thin, cord-like structure that carries the electrical signal to the right ventricle. The left bundle branch is quite different. It’s a broad, fan-shaped structure, up to 14 millimeters wide, that further divides into an anterior fascicle and a posterior fascicle (and sometimes a septal fascicle). These fascicles spread the electrical impulse across the entire left ventricular wall through a network of tiny fibers called Purkinje fibers.

When everything works correctly, the electrical signal reaches both ventricles almost simultaneously, and they contract in a coordinated, synchronized fashion. This synchronized contraction is what allows your heart to pump blood efficiently.

What Happens When the Left Bundle Branch Is Blocked

In LBBB, the electrical signal can no longer travel through the left bundle branch normally. It may be completely blocked or significantly delayed. When this happens, the left ventricle can’t receive its electrical activation through the fast Purkinje fiber network the way it’s supposed to.

Instead, the electrical signal has to take a detour. It first activates the right ventricle normally through the intact right bundle branch, and then it spreads to the left ventricle through slow cell-to-cell conduction across the muscular wall between the ventricles (the septum). This detour is much slower than the normal pathway. Instead of both ventricles contracting in sync, the right ventricle activates first and the left ventricle follows with a delay.

This delay shows up on the ECG as a widened QRS complex, the part of the ECG tracing that represents ventricular contraction. Normally, the QRS complex is narrow, lasting less than 120 milliseconds. In LBBB, the QRS widens to 120 milliseconds or more because the left ventricle takes longer to activate. The wider the QRS, generally, the more significant the conduction delay.

The ECG also shows characteristic changes in the shape of the QRS complex. Instead of a sharp, crisp deflection, you see broad, notched, or slurred waves in certain leads. The T waves (which represent the heart's electrical recovery after each beat) typically point in the opposite direction of the QRS complex.

What LBBB Means for Your Heart's Function

Here's something that might surprise you: even in an otherwise healthy heart, LBBB causes an immediate reduction in how efficiently the left ventricle pumps. The electrical dyssynchrony (the delayed activation of the left ventricle) translates directly into mechanical dyssynchrony (the left ventricle isn't contracting in a coordinated way).

Think of it like a rowing team. When everyone rows in sync, the boat moves forward powerfully and efficiently. If half the rowers are a beat behind, the boat still moves, but it's slower, less efficient, and wastes energy. That's essentially what happens to your left ventricle with LBBB.

Research has shown that LBBB can reduce the left ventricular ejection fraction (the percentage of blood the left ventricle pumps out with each beat) to approximately 55% immediately, even in a heart that was previously normal. While 55% is still technically in the normal range, it represents a measurable drop from what the heart would otherwise achieve.

Over time, this chronic inefficiency can lead to adverse ventricular remodeling, a process where the heart gradually changes shape, enlarges, and weakens. This remodeling can progress through stages: first, the heart may function reasonably well (what we call heart failure with preserved ejection fraction, or HFpEF), then it may enter a middle zone (heart failure with mildly reduced ejection fraction, or HFmrEF), and eventually it may develop into overt heart failure with significantly reduced pumping strength (HFrEF). This progression can take anywhere from a few years to two decades, and it doesn't happen in everyone, but it's the reason we take LBBB seriously even in patients who feel fine.

What Causes LBBB

LBBB can develop for several reasons, and identifying the underlying cause is one of the most important parts of my evaluation.

Chronic degenerative changes are the most common cause, particularly in older patients. Over time, the conduction system can develop fibrosis (scarring) or calcification, particularly at the junction where the left bundle branch connects to the main His bundle. This process, sometimes called Lenègre disease, happens gradually with aging. It can be accelerated by long-standing mechanical stress on the conduction system from conditions like high blood pressure or an enlarged heart.

Hypertension and left ventricular hypertrophy are frequent culprits. When the heart has been pumping against elevated blood pressure for years, the left ventricle thickens (hypertrophies). This thickening can compress the left bundle branch between the growing muscle and the connective tissue of the septum, eventually impairing conduction.

Ischemic heart disease (coronary artery disease) can cause LBBB, though the relationship is nuanced. An acute heart attack can produce new LBBB, but this requires either damage right at the origin of the left bundle branch or extensive muscle damage involving the areas supplied by both fascicles, typically from a large anterior heart attack. More commonly, LBBB in patients with coronary disease is a chronic finding related to years of reduced blood flow and gradual scarring rather than a sudden event.

Cardiomyopathy, whether caused by coronary disease, viral infection, alcohol, genetics, or other factors, is frequently associated with LBBB. As the heart muscle weakens and the chambers enlarge, the conduction system stretches and becomes dysfunctional. In some cases, LBBB contributes to the cardiomyopathy itself, creating a chicken-and-egg situation where the conduction abnormality and the heart muscle weakness worsen each other.

Aortic valve disease, particularly calcific aortic stenosis, can affect the conduction system because of the close proximity of the aortic valve to the left bundle branch. Patients who undergo transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement develop new LBBB at significant rates because the procedure can cause direct mechanical trauma, swelling, or compression of the conduction fibers near the aortic annulus.

Idiopathic LBBB, meaning LBBB without any identifiable cause, is relatively uncommon, occurring in roughly 0.1% of the general population. When I see what appears to be isolated LBBB, I'm cautious about accepting it at face value. Studies using cardiac MRI have shown that about one-third of patients with apparently isolated LBBB and normal echocardiograms actually have subclinical cardiomyopathy that wasn't visible on ultrasound.

How Common Is LBBB?

LBBB occurs in less than 1% of the general population, but its prevalence increases significantly with age. By age 80, approximately 5% of people have LBBB. Among patients with coronary artery disease, the prevalence is around 4-5%. In patients with heart failure, LBBB is much more common, present in roughly 25-30% of cases.

The condition affects both men and women, though the clinical implications can differ. Interestingly, women with LBBB who receive certain treatments (particularly cardiac resynchronization therapy) tend to respond better than men, a finding that has influenced treatment guidelines.

When Is LBBB Benign? When Is It Concerning?

This is the question every patient asks, and the answer depends on several factors.

LBBB is more likely to be benign when it occurs in isolation, without any evidence of structural heart disease. If your echocardiogram shows normal heart size, normal wall thickness, normal valve function, and a normal ejection fraction, and if you have no symptoms of heart disease, the prognosis is generally favorable. Some patients with isolated LBBB live entirely normal lives without any progression to heart problems.

LBBB becomes more concerning in several situations. If your echocardiogram shows reduced ejection fraction, enlarged chambers, or valve abnormalities, the LBBB is likely a marker of significant underlying disease. If you're experiencing symptoms like shortness of breath, fatigue, exercise intolerance, or lightheadedness, the LBBB may be contributing to your symptoms by impairing your heart's pumping efficiency. If the LBBB is new, meaning it wasn't present on a previous ECG, that raises the question of what changed in your heart to cause it.

Even when LBBB appears isolated, I remain watchful. The data tells us that patients with LBBB have higher rates of subsequent heart failure, cardiovascular events, and cardiac death compared to matched individuals without LBBB. A recent study published in JAMA Network Open confirmed that LBBB is an independent risk factor for developing heart failure over time. The risk isn't dramatic in any given year, but it accumulates, which is why ongoing monitoring matters.

The progression from LBBB to complete heart block (where the electrical connection between the upper and lower chambers fails entirely) is relatively uncommon, occurring at roughly 1% per year. But it's another reason we keep an eye on patients with LBBB over time.

What to Expect: The Workup After an LBBB Diagnosis

When I identify LBBB on a patient's ECG, my evaluation follows a systematic approach tailored to the clinical picture.

Echocardiogram is the first test I order for every patient with newly discovered LBBB. This ultrasound of the heart gives me detailed information about the size of your heart chambers, the thickness of the heart walls, how well the valves are working, and the ejection fraction (pumping strength). The echocardiogram helps me determine whether the LBBB is an isolated electrical finding or whether it's associated with structural heart disease. If the echo is normal, that's reassuring. If it shows abnormalities, it guides my next steps.

Blood work is part of the initial workup. I check for conditions that can affect the heart, including thyroid function, kidney function, electrolytes, and sometimes B-type natriuretic peptide (BNP or NT-proBNP), a blood test that helps detect heart failure.

Stress testing may be indicated depending on your risk factors and symptoms. However, interpreting stress tests in patients with LBBB requires special consideration. The ECG changes caused by LBBB can mimic the changes we look for during stress testing to diagnose coronary artery disease, leading to false-positive results. For this reason, I typically recommend a nuclear stress test or stress echocardiogram rather than a standard treadmill ECG stress test when evaluating patients with LBBB for possible coronary disease.

Cardiac MRI is increasingly valuable in LBBB evaluation. MRI can detect subtle abnormalities in the heart muscle that echocardiography misses, including early cardiomyopathy, myocardial fibrosis, and inflammation. As I mentioned earlier, cardiac MRI has been shown to detect subclinical cardiomyopathy in about one-third of patients with LBBB and apparently normal echocardiograms. I consider cardiac MRI particularly useful in younger patients with newly discovered LBBB, patients with borderline echocardiographic findings, or when the cause of LBBB remains unclear after initial testing.

Coronary evaluation may be warranted if there's concern for ischemic heart disease, especially in patients with cardiovascular risk factors, symptoms of angina, or abnormal stress test results.

Cardiac Resynchronization Therapy: Restoring the Rhythm

For patients who develop heart failure in the setting of LBBB, one of the most effective treatments available is cardiac resynchronization therapy (CRT), also known as biventricular pacing.

The concept behind CRT is elegant. Since LBBB causes the left ventricle to contract out of sync with the right ventricle, CRT aims to restore synchrony by pacing both ventricles simultaneously. A CRT device is similar to a pacemaker but has an additional lead (wire) placed in a vein on the surface of the left ventricle (through the coronary sinus). By delivering carefully timed electrical impulses to both ventricles at once, CRT can reverse the mechanical dyssynchrony caused by LBBB.

The evidence supporting CRT in LBBB patients is among the strongest in all of cardiology. The MADIT-CRT trial enrolled over 1,800 patients with mild heart failure and reduced ejection fraction. In patients with LBBB, CRT reduced the combined risk of heart failure events or death by 53%. Long-term follow-up at seven years showed sustained survival benefit, with mortality of 18% in the CRT group compared to 29% in the group that received an ICD alone. Patients without LBBB showed no benefit from CRT, confirming that LBBB is the key predictor of who responds to this therapy.

The REVERSE trial demonstrated that CRT produces significant reverse remodeling in LBBB patients, meaning the heart actually gets smaller and stronger over time. Left ventricular volumes decreased substantially, and there was a 53% reduction in time to first heart failure hospitalization.

The RAFT trial showed a 25% reduction in death from any cause with CRT, and remarkably, this benefit persisted during nearly 14 years of follow-up. This is one of the longest-term follow-up studies in device therapy, and it confirms that CRT provides durable, lasting benefit.

Current guidelines give the strongest recommendation (Class I) for CRT in patients with LBBB who have an ejection fraction of 35% or less, are in sinus rhythm, have a QRS duration of 150 milliseconds or wider, and remain symptomatic despite optimal medical therapy. The wider the QRS and the more classic the LBBB pattern, the better the response to CRT tends to be. Women with LBBB appear to respond particularly well to CRT, with better survival outcomes than men in multiple studies.

The Future: Conduction System Pacing

One of the most exciting developments in my field is conduction system pacing (CSP), which includes His bundle pacing and left bundle branch area pacing (LBBAP).

Traditional CRT works by pacing the left ventricle from the outside (epicardially, via a lead in the coronary sinus). Conduction system pacing takes a different approach: it directly engages the heart's own conduction system to restore normal or near-normal electrical activation.

His bundle pacing involves placing a pacing lead directly on the His bundle, the structure just above where the bundle branches divide. In patients with LBBB where the block is located within the His bundle itself, pacing at this point can sometimes "get past" the block and restore normal conduction down the left bundle branch. When it works, the result is remarkably physiologic, producing a narrow QRS complex and truly synchronized ventricular contraction.

Left bundle branch area pacing is a newer technique where the pacing lead is advanced through the septum to capture the left bundle branch directly. This approach has higher success rates than His bundle pacing and typically achieves lower, more stable pacing thresholds. Early evidence suggests that LBBAP may be as effective as traditional CRT for many patients, with the advantage of simpler implantation (only two leads needed instead of three) and more reliable capture.

The 2025 ESC Clinical Consensus Statement on conduction system pacing has formalized indications for these techniques, and they are increasingly being offered as alternatives to traditional CRT. In my own practice, I discuss conduction system pacing with appropriate patients, particularly those in whom coronary sinus lead placement may be difficult or who want the most physiologic pacing approach available.

Living with LBBB: Monitoring and Follow-Up

If you've been diagnosed with LBBB, here's what I recommend for ongoing care.

Regular echocardiograms are the cornerstone of monitoring. If your initial echocardiogram is normal, I typically repeat it in 6-12 months to look for any early changes, and then periodically thereafter (usually every 1-2 years, depending on your overall clinical picture). We're watching for any decline in ejection fraction, any increase in chamber sizes, or any new valve abnormalities that might indicate the LBBB is starting to take a toll.

Symptom awareness matters. Pay attention to how you feel during daily activities. New shortness of breath, decreased exercise tolerance, swelling in your legs or ankles, fatigue that's worse than your baseline, or episodes of lightheadedness should prompt a call to your cardiologist. These symptoms can develop gradually and are easy to dismiss as "getting older," but in the context of LBBB, they warrant evaluation.

Annual ECGs help me track whether the LBBB pattern is stable or changing. Widening of the QRS over time, development of additional conduction abnormalities, or changes in heart rate can influence management decisions.

Risk factor management is especially important for LBBB patients. Controlling blood pressure, maintaining a healthy weight, managing cholesterol, treating diabetes, exercising regularly, and avoiding tobacco all help protect a heart that already has a conduction abnormality. You want to minimize any additional stress on the system.

Medication management depends on whether you have underlying heart disease. If LBBB is truly isolated and your heart function is normal, you may not need any heart-specific medications. If there's evidence of heart failure or reduced ejection fraction, guideline-directed medical therapy (which may include beta-blockers, ACE inhibitors or ARBs, mineralocorticoid receptor antagonists, and SGLT2 inhibitors) becomes very important.

LBBB and Special Situations

There are a few clinical scenarios worth mentioning because patients frequently ask about them.

LBBB and heart attacks. Historically, new LBBB was considered equivalent to an ST-elevation heart attack (STEMI) and triggered emergency catheterization. Current thinking is more nuanced. While new LBBB can indicate an acute heart attack, it can also occur for other reasons. Modern guidelines emphasize using the full clinical picture, including symptoms, cardiac biomarkers (troponin), and other ECG changes, rather than relying on LBBB alone to diagnose a heart attack. If you develop sudden chest pain, shortness of breath, or other heart attack symptoms and have known LBBB, call 911 immediately. Let the emergency team sort out the cause.

LBBB and exercise testing. As I mentioned, standard treadmill ECG stress testing is unreliable in patients with LBBB because the conduction abnormality produces ST-segment changes that mimic ischemia. In my practice, I always use imaging-based stress tests (nuclear perfusion or stress echocardiography) for LBBB patients who need coronary evaluation. If you're scheduled for a stress test and you have LBBB, make sure your ordering physician is aware.

LBBB after TAVR or cardiac surgery. New LBBB develops in a significant proportion of patients after transcatheter aortic valve replacement. In some cases, the LBBB resolves within days to weeks as swelling around the conduction system subsides. In others, it persists. Patients who develop persistent LBBB after TAVR need close monitoring of their heart function, as some will experience a decline in ejection fraction over time that may require further intervention.

Rate-dependent LBBB. Some patients develop LBBB only when their heart rate exceeds a certain threshold. The conduction block appears during exercise or stress and resolves at rest. This pattern, called rate-dependent or tachycardia-dependent LBBB, suggests that the left bundle branch is functioning at its limit and can't keep up with faster rates. It warrants the same evaluation as persistent LBBB.

What I Tell My Patients

When I sit down with a patient who's just learned they have LBBB, I try to put the finding in perspective. I explain that LBBB is not a heart attack, not an emergency, and not an automatic sentence of heart failure. It's an electrical finding that tells us something has changed in the way your heart conducts electricity, and it's our job to figure out why and what it means for you specifically.

For some patients, LBBB will turn out to be an incidental finding that requires monitoring but no active treatment. For others, it will be the clue that leads us to diagnose and treat an underlying condition. And for patients who do develop heart failure in the setting of LBBB, cardiac resynchronization therapy is one of the most effective treatments in all of cardiology, with proven long-term benefits that last well over a decade.

The most important thing is not to ignore it. Get your echocardiogram. Follow up with your cardiologist. Pay attention to your symptoms. And take care of the risk factors you can control. LBBB is manageable, and with appropriate evaluation and monitoring, the vast majority of my patients with LBBB continue to live active, full lives.

If you have questions about LBBB or any findings on your ECG, I encourage you to schedule an appointment at San Diego Cardiovascular Associates in Encinitas. We can review your ECG, perform the appropriate testing, and develop a follow-up plan tailored to your specific situation.

References

Kusumoto, Fred M., Mark H. Schoenfeld, Coletta Barrett, et al. "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay." Journal of the American College of Cardiology 74, no. 7 (2019): e51-e156.

Chelu, Mihail G., Jeanne E. Poole, and Kenneth A. Ellenbogen. "Physiologic Pacing in Heart Failure." New England Journal of Medicine (2026).

Neeland, Ian J., Michael C. Kontos, and James A. de Lemos. "Evolving Considerations in the Management of Patients with Left Bundle Branch Block and Suspected Myocardial Infarction." Journal of the American College of Cardiology 60, no. 2 (2012): 96-105.

Treger, Jonathan S., Ahmad B. Allaw, Parham Razminia, et al. "A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I." JAMA Cardiology (2024).

Auffret, Vincent, Raphael P. Martins, and Christophe Daubert. "Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review." Journal of the American College of Cardiology 72, no. 24 (2018): 3177-3188.

Goldenberg, Ilan, Valentina Kutyifa, Helmut U. Klein, et al. "Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure." New England Journal of Medicine 370, no. 18 (2014): 1694-1701.

Sapp, John L., Satish Sivakumaran, Chris J. Redpath, et al. "Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure." New England Journal of Medicine 390, no. 3 (2024): 212-220.

Thein, Aung S., Saman Dixit, and Elsayed Z. Soliman. "Left Bundle Branch Block as a Risk Factor for Heart Failure." JAMA Network Open (2025).

Darmon, Arthur, Gregory Ducrocq, Yedid Elbez, et al. "Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes." American Journal of Cardiology 148 (2021): 26-33.

Tan, Nicholas Y., Christine M. Witt, Jae K. Oh, and Yong-Mei Cha. "Left Bundle Branch Block: Current and Future Perspectives." Circulation: Arrhythmia and Electrophysiology 13, no. 4 (2020): e008239.

Glikson, Michael, Haran Burri, Amin Abdin, et al. "European Society of Cardiology (ESC) Clinical Consensus Statement on Indications for Conduction System Pacing." Europace (2025).